Total submissions: 8
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Department of Pathology and Laboratory Medicine, |
RCV003974816 | SCV006055541 | benign | SERPINA7-related disorder | 2023-04-24 | criteria provided, single submitter | research | |
| Breakthrough Genomics, |
RCV001610288 | SCV005276373 | benign | not provided | criteria provided, single submitter | not provided | ||
| Gene |
RCV001610288 | SCV001838584 | benign | not provided | 2021-02-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 33554479, 2155256, 1515456, 25333069) |
| Prevention |
RCV003974816 | SCV004790798 | benign | SERPINA7-related disorder | 2019-11-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
| Department of Endocrinology, |
RCV002264638 | SCV002546359 | likely risk allele | Thyroxine-binding globulin quantitative trait locus | no assertion criteria provided | clinical testing | ||
| Diagnostic Laboratory, |
RCV001699178 | SCV001962915 | benign | not specified | no assertion criteria provided | clinical testing | ||
| Clinical Genetics, |
RCV001699178 | SCV001918733 | benign | not specified | no assertion criteria provided | clinical testing | ||
| OMIM | RCV000010442 | SCV000030668 | pathogenic | Thyroxine-binding globulin, variant P | 1992-03-01 | no assertion criteria provided | literature only |